Tag: Vaccine
JNU researchers identify promising protein for malaria vaccine
The research, conducted in collaboration with the Indian Council of Medical Research (ICMR), focused on identifying a protein called Prohibitin 2 (PfPHB2) in the malaria parasite
Dr Krishna Ella awarded by Johns Hopkins Bloomberg School for exceptional...
The Dean's Medal recognises exceptional leadership in safeguarding and improving global public health
Serum Institute ships first set of 43,200 malarial vaccine doses to...
The initial shipment will be sent to the Central African Republic (CAR), followed by other African countries such as South Sudan and Democratic Republic of Congo in the next coming days
Serum Institute to acquire 20% stake in IntegriMedical, India’s first needle-free...
The investment by SII in IntegriMedical is expected to accelerate the development and commercialization of the N-FIS technology, making it more widely accessible to patients in India and worldwide
Bharat Biotech reiterates its assurance on safety of Covaxin
As per company, the vaccine hasn't reported any incidents of blood clots, Thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc.
Dr Krishna Ella takes over as new President of Indian Vaccine...
Dr Ella takes over the Presidency from Mr. Adar C Poonawala who held the post from 2019 to March 2024
Viral Hepatitis is a public health problem requiring urgent attention, say...
The recently released Global Hepatitis Report 2024 by World Health Organisation has data which is of severe concern to India
IIT Guwahati collaborates with BioMed to roll out first recombinant vaccine...
The technology has been successfully transferred to BioMed for the commercial production of this innovative vaccine
Bharat Biotech begins clinical trials of Spanish TB vaccine, MTBVAC in...
MTBVAC is being developed for two purposes: as a more effective and potentially longer-lasting vaccine than BCG for newborns, and for the prevention of TB disease in adults
Cadila Pharma introduces Quadrivalent Influenza Vaccine in India
Vaccine targets four strains of the Influenza virus subtype–A and B, responsible for seasonal epidemics